共 15 条
[1]
[2]
[3]
Expression of β-catenin in hepatocellular carcinoma[J] Liem Thanh Tien;Masahiro Ito;Mikiko Nakao;Daisuke Niino;Meirmanov Serik;Masahiro Nakashima;Chun-Yang Wen;Hiroshi Yatsuhashi;Hiromi Ishibashi; World Journal of Gastroenterology 2005,
[4]
Wnt signaling in disease and in development[J] Roel NUSSE Cell Research 2005, 01
[5]
p53; MDM2; eIF4E and EGFR expression in nasopharyngeal carcinoma andtheir correlation with clinicopathological characteristics and prognosis: A retrospectivestudy[J] Peng Zhang;Song?Ke Wu;Ying Wang;Zi?Xuan Fan;Chu?Rong Li;Mei Feng;Peng Xu;Wei?Dong Wang;Jin?Yi Lang Oncology Letters 2015,
[6]
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response[J] Luca Azzolin;Tito Panciera;Sandra Soligo;Elena Enzo;Silvio Bicciato;Sirio Dupont;Silvia Bresolin;Chiara Frasson;Giuseppe Basso;Vincenza Guzzardo;Ambrogio Fassina;Michelangelo Cordenonsi;Stefano Piccolo Cell 2014,
[7]
Downregulation of γ-catenin inhibits CML cell growth and potentiatesthe response of CML cells to imatinib through β-catenin inhibition[J] Chang-Chun Niu;Chen Zhao;Zhen-Dong Yang;Xiao-Li Zhang;Wei-Ru Wu;Jing Pan;Chen Zhao;Zhi-Qiang Li;Wei Ding;Zhong Yang;Wei-Ke Si International Journal of Molecular Medicine 2013,
[8]
Cancer stem‐like cell properties are regulated by EGFR / AKT /β–catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma[J] Lei Ma;Gong Zhang;Xiao‐Bo Miao;Xu‐Bin Deng;Yue Wu;Ying Liu;Zhi‐Ru Jin;Xi‐Qing Li;Qiu‐Zhen Liu;Du‐Xin Sun;Joseph R. Testa;Kai‐Tai Yao;Guang‐Hui Xiao FEBS J 2013,
[9]
New Insights into the Mechanism of Wnt Signaling Pathway Activation[J] Akira Kikuchi;Hideki Yamamoto;Akira Sato;Shinji Matsumoto International Review of Cell and Molecular Biology 2011,
[10]
Overexpression of Axin Downregulates TCF-4 and Inhibits the Development of Lung Cancer[J] Hong-Tao Xu;Qiang Wei;Yang Liu;Lian-He Yang;Shun-Dong Dai;Yang Han;Juan-Han Yu;Nan Liu;En-Hua Wang Annals of Surgical Oncology 2007,

